|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006938,
umls-concept:C0025250,
umls-concept:C0030705,
umls-concept:C0033607,
umls-concept:C0077782,
umls-concept:C0205177,
umls-concept:C0205531,
umls-concept:C0226896,
umls-concept:C0264716,
umls-concept:C0442027,
umls-concept:C1527415,
umls-concept:C1707455
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2000-8-30
|
|
pubmed:abstractText |
To compare the effects on exercise capacity of the neutral endopeptidase inhibitor candoxatril, and the angiotensin converting enzyme inhibitor captopril, in patients with mild to moderate heart failure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1388-9842
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
67-72
|
|
pubmed:dateRevised |
2011-6-8
|
|
pubmed:meshHeading |
pubmed-meshheading:10937982-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:10937982-Captopril,
pubmed-meshheading:10937982-Double-Blind Method,
pubmed-meshheading:10937982-Exercise Test,
pubmed-meshheading:10937982-Exercise Tolerance,
pubmed-meshheading:10937982-Female,
pubmed-meshheading:10937982-Heart Failure,
pubmed-meshheading:10937982-Humans,
pubmed-meshheading:10937982-Indans,
pubmed-meshheading:10937982-Male,
pubmed-meshheading:10937982-Middle Aged,
pubmed-meshheading:10937982-Propionates,
pubmed-meshheading:10937982-Protease Inhibitors
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure.
|
|
pubmed:affiliation |
Department of Cardiology, Western General Hospital, Edinburgh, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
